🔗 Share this article

A shadow market for unapproved weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Treatment Gaining Popularity Online

The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share comparison images, administration instructions and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and chemists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in users administering substances of unknown origin.

Some professionals said the popularity for retatrutide could be connected to the rising cost of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Material Elimination

According to the social media company, the service has taken down problematic content and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the service secure and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Research also discovered communities with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with thousands of members, populated with photos of slimming results, positive reviews and detailed instructions for preparing or injecting at home.

Within moments of entering one community, a vendor shared WhatsApp details, where the majority of transactions occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, medical conditions or previous experience.

Product Information and Pricing

Within these communities, posts show black plastic parcels with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how long a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service said it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has previously seen individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject users to potentially significant medical dangers”.